Inhibitors
    1.
    发明申请
    Inhibitors 审中-公开
    抑制剂

    公开(公告)号:US20070249915A1

    公开(公告)日:2007-10-25

    申请号:US10574469

    申请日:2004-09-30

    IPC分类号: A61B5/00

    CPC分类号: C12Q1/6883 C12Q2600/158

    摘要: The present invention provides a skin test method for predicting the formation of spots in the skin. This method judges skin to be susceptible to the formation of spots in the case expression in the epidermis of MCP-2 gene, a polynucleotide capable of hybridizing under highly stringent conditions to mouse AK012157 gene, human FLJ21763 gene or rat S74257 gene, or Mcp9, Mcp10, Isg15, Usp18, Oas12, Gbp2, Gtpi, Ifi47, Igtp, Tgtp, Sprr2A, Krt2-6b, Cdk5rap2, Mef2C, Gsta4, Osf2, Tnc, Igfbp6, Ppicap or Mm. 74656 gene, is increased as compared with normal expression in the epidermis.

    摘要翻译: 本发明提供一种用于预测皮肤斑点形成的皮肤试验方法。 该方法可以判断皮肤易于在MCP-2基因的表皮中表达的斑点形成,该基因是能够在高度严格条件下与小鼠AK012157基因,人FLJ21763基因或大鼠S74257基因或Mcp9基因杂交的多核苷酸, Mcp10,Isg15,Usp18,Oas12,Gbp2,Gtpi,Ifi47,Igtp,Tgtp,Sprr2A,Krt2-6b,Cdk5rap2,Mef2C,Gsta4,Osf2,Tnc,Igfbp6,Ppicap或Mm。 74656基因与表皮正常表达相比增加。

    Method of predicting spot formation on the skin using spot site-accelerating genes as an indicator thereof and method of screening inhibitors of spot formation on the skin
    2.
    发明授权
    Method of predicting spot formation on the skin using spot site-accelerating genes as an indicator thereof and method of screening inhibitors of spot formation on the skin 失效
    使用斑点位点加速基因作为指标预测皮肤上的斑点形成的方法和筛选皮肤上斑点形成抑制剂的方法

    公开(公告)号:US08142761B2

    公开(公告)日:2012-03-27

    申请号:US12226656

    申请日:2007-04-24

    IPC分类号: A61K49/00

    摘要: The present invention provides a skin test method for predicting the formation of spots in the skin. This method is characterized by judging skin to be susceptible to spot formation in the case expression of genes consisting of MLSTD1, MOGAT1, FADS2, FADS1, HSD3B1, ELOVL3, BG1, PECR, FABP7, FA2H, HAO2, ALOX15B, PDE6A, LZTS1, SEC14L4, BAMBI, CIDEA, TERE1, GAL, THRSP, INSIG1 or CUTL2 in the epidermis is accelerated, or the expression of genes consisting of RBBP6, MSMB, WIF1, ANKRD12, FLG, SYNE2, SCEL, NKTR or AMBP in the epidermis is decreased as compared with normal expression in the epidermis.

    摘要翻译: 本发明提供一种用于预测皮肤斑点形成的皮肤试验方法。 该方法的特征在于在由MLSTD1,MOGAT1,FADS2,FADS1,HSD3B1,ELOVL3,BG1,PECR,FABP7,FA2H,HAO2,ALOX15B,PDE6A,LZTS1,SEC14L4组成的基因的病例表达中判断皮肤易发生斑点形成 表皮中的BAMBI,CIDEA,TERE1,GAL,THRSP,INSIG1或CUTL2被加速,或者表皮中由RBBP6,MSMB,WIF1,ANKRD12,FLG,SYNE2,SCEL,NKTR或AMBP组成的基因的表达减少为 与正常表皮相比较。

    Method of Predicting Spot Formation on the Skin Using Spot Site-Accelerating Genes as an Indicator Thereof and Method of Screening Inhibitors of Spot Formation on the Skin
    3.
    发明申请
    Method of Predicting Spot Formation on the Skin Using Spot Site-Accelerating Genes as an Indicator Thereof and Method of Screening Inhibitors of Spot Formation on the Skin 失效
    使用现场加速基因作为指标预测皮肤斑点形成的方法和筛选皮肤上斑点形成抑制剂的方法

    公开(公告)号:US20090123401A1

    公开(公告)日:2009-05-14

    申请号:US12226656

    申请日:2007-04-24

    IPC分类号: C12Q1/68 A61K45/00 A61Q19/02

    摘要: The present invention provides a skin test method for predicting the formation of spots in the skin. This method is characterized by judging skin to be susceptible to spot formation in the case expression of genes consisting of MLSTD1, MOGAT1, FADS2, FADS1, HSD3B1, ELOVL3, BG1, PECR, FABP7, FA2H, HAO2, ALOX15B, PDE6A, LZTS1, SEC14L4, BAMBI, CIDEA, TERE1, GAL, THRSP, INSIG1 or CUTL2 in the epidermis is accelerated, or the expression of genes consisting of RBBP6, MSMB, WIF1, ANKRD12, FLG, SYNE2, SCEL, NKTR or AMBP in the epidermis is decreased as compared with normal expression in the epidermis.

    摘要翻译: 本发明提供一种用于预测皮肤斑点形成的皮肤试验方法。 该方法的特征在于在由MLSTD1,MOGAT1,FADS2,FADS1,HSD3B1,ELOVL3,BG1,PECR,FABP7,FA2H,HAO2,ALOX15B,PDE6A,LZTS1,SEC14L4组成的基因的病例表达中判断皮肤易发生斑点形成 表皮中的BAMBI,CIDEA,TERE1,GAL,THRSP,INSIG1或CUTL2被加速,或者表皮中由RBBP6,MSMB,WIF1,ANKRD12,FLG,SYNE2,SCEL,NKTR或AMBP组成的基因的表达减少为 与正常表皮相比较。